Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease

American Journal of Pathology

Volumn 152, Issue 1, 1998, Pages 261-268

  Müller, Stefan ^a   Lory, Jon ^a   Corazza, Nadia ^a   Griffiths, Gillian M ^b   Z'graggen, Kaspar ^a,c   Mazzucchelli, Luca ^a,d   Kappeler, Andreas ^a   Mueller, Christoph ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GRANZYME A; MESSENGER RNA; PERFORIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENTERITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE MUCOSA; LAMINA PROPRIA; MALE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 2642706700     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Okazaki K, Morita M, Nishimori I, Sano S, Toyonaga M, Nakazawa Y, Yamamoto Y, Yamamoto Y: Major histocompatibility antigen-restricted cytotoxicity in inflammatory bowel disease. Gastroenterology 1993, 104:384-391
2. Egawa S, Hiwatashi N: Natural killer cell activity in patients with inflammatory bowel disease J Clin Lab Immunol 1986, 20:187-192
3. Ginsburg CH, Dambrauskas JT, Ault KA, Falchuk ZM: Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect. Gastroenterology 1983, 85:846-851
4. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S: Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993, 75:274-282
5. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261
6. Kühn R, Lohler J, Rennick D, Rajewski K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274
7. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Boulay G, Bradley A, Birnbaumer L: Ulcerative colitis and adenocarcinoma of the colon in Gα i2-deficient mice. Nature Genet 1995, 10:143-150
8. + T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995, 25:2618-2625
9. Holländer GA, Simpson SJ, Mizoguchi E, Nichogiannopoulou A, She J, Gutierrez-Ramos JC, Bhan AK, Burakoff SJ, Wang B, Terhorst C: Severe colitis in mice with aberrant thymic selection. Immunity 1995, 3:27-38
10. Griffiths GM, Mueller C: Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991, 12:415-419
11. 2+-independent T cell-mediated cytotoxicity. J Exp Med 1993, 177:195-200
12. + T cell-mediated cytotoxicity. J Immunol 1994, 152:1127-1133
13. Henkart PA: Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1994, 1:343-346
14. Rüthlein J, Heinze G, Auer IO: Anti-CD2 and anti-CD3 induced T cell cytotoxicity of human intraepithelial and lamina propria lymphocytes. Gut 1992, 33:1626-1632
15. Gershenfeld HK, Hershberger RJ, Shows TB, Weissman IL: Cloning and chromosomal assignment of a human cDNA encoding a T cell-and natural killer cell-specific trypsin-like serine protease. Proc Natl Acad Sci USA 1988, 85:1184-1188
16. Lichtenheld MG, Olsen KJ, Lu P, Lowrey DM, Hameed A, Hengartner H, Podack ER: Structure and function of human perforin. Nature 1988, 335:448-451
17. Mueller C, Gershenfeld HK, Lobe CG, Okada CY, Bleackley RC, Weissman IL: A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the Mel-14-defined lymph node homing receptor. J Exp Med 1988, 167:1124
18. Baetz K, Isaaz S, Griffiths GM: Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis. J Immunol 1995, 154:6122-6131
19. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM: Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to Interleukin 8. J Exp Med 1991, 174:1355-1362
20. Eckmann L, Jung HC, Schürer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF: Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993, 105:1689-1697
21. Eckmann L, Kagnoff MF, Fierer J: Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 1993, 61:4569-4574
22. Schürer-Maly CC, Eckmann L, Kagnoff MF, Falco MT, Maly FE: Co-Ionic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 1994, 81:85-91
23. Mazzucchelli L, Hauser C, Z'graggen K, Wagner H, Hess M, Laissue JA, Mueller C: Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994, 144:997-1007
24. Z'Graggen K, Walz A, Mazzucchelli L, Strieter R, Mueller C: The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 1997, 113:808-816
25. + CTL that utilizes a perforin-rather than a Fas ligand-dependent cytotoxic mechanism. J Immunol 1996, 156:153-159
26. Simpson SJ, Holländer GA, Mizoguchi E, Bhan AK, Wang B, Terhorst C: Defects in T-cell regulation: lessons for inflammatory bowel disease. Essentials of Mucosal Immunology. Edited by Kagnoff MF, Kiyono H. New York, Academic Press, 1996, pp 291-304
27. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, Pallone F: Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997, 112:1169-1178
28. Parronchi P, Romagnani P, Annuziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S: Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997, 150:823-832